VICTORIA, June 12, 2017 /CNW/ - Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX:TBQBF) ("Emerald" or the "Company") is pleased to announce it has qualified for trading on the OTCQX® Best Market, operated by OTC Markets Group. The Company begins trading today on the OTCQX under the ticker symbol "TBQBF".
"We look forward to being more visible and investable for U.S. investors by trading on the OTCQX Market," said Avtar Dhillon, MD, Executive Chairman of Emerald Health Therapeutics. "With the recent announcement of our transformational joint venture with Village Farms International, a leader in greenhouse growing, we view trading on the OTCQX Market as the logical next step for building awareness, visibility, and liquidity for the company and its shareholders."
"We welcome Emerald Health Therapeutics to our family of established, investor-focused OTCQX companies," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "Trading on OTCQX will enable Emerald Health to leverage its existing TSX Venture listing and provide an efficient and transparent trading market for U.S. investors. We look forward to supporting Emerald Health's continued growth."
U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
Emerald Health Therapeutics was sponsored for OTCQX by McMillan LLP, a qualified 3rd party firm responsible for providing guidance on OTCQX requirements and recommending membership.
Join us on our journey of making lives better through cannabis science.
Emerald Health Therapeutics Inc.
Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX:TBQBF) operates primarily through Emerald Health Botanicals Inc. ("Botanicals"), a wholly owned subsidiary of the Company and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"). Botanicals is authorized to cultivate and sell both dried medical cannabis flowers and medical cannabis oils in Canada. Botanicals currently operates an indoor cultivation facility in Victoria, British Columbia, and plans to construct a much larger purpose built hybrid greenhouse facility on 32 acres in metro Vancouver. Botanicals prides itself on being one of Canada's most medically focused licensed producers and on having one of the industry's most qualified management teams with respect to pharmaceutical drug discovery, development and distribution. Botanicals intends to capture unique niches in both the medical and future adult use cannabis markets through its proprietary strains, defensible intellectual property, and superb client experience.
Please visit http://www.emeraldhealth.ca/ for more information.
"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."
SOURCE Emerald Health Therapeutics, Inc.
For further information: Sandy Pratt, CFO, 250-818-9838, [email protected]